Comparison of provincial and territorial legislation governing substitute consent for research

Canadian Journal on Aging

Volumn 24, Issue 3, 2005, Pages 237-250

  Bravo, Gina ^a,b   Gagnon, Michaël ^b   Wildeman, Sheila ^c   Marshall, David T ^d   Pâquet, Mariane ^b   Dubois, Marie France ^a,b  

^a UNIVERSITY OF SHERBROOKE   (Canada)

^b UNIVERSITY INSTITUTE OF GERIATRICS OF SHERBROOKE   (Canada)

^c DALHOUSIE UNIVERSITY   (Canada)

^d UNIVERSITY OF OTTAWA HEART INSTITUTE   (Canada)

Author keywords

Aging; Consent; Decisional incapacity; Health care; Law; Research

Indexed keywords

ARTICLE; CANADA; COGNITIVE DEFECT; DECISION MAKING; GOVERNMENT; HUMAN; LAW; LEGAL ASPECT; MEDICAL RESEARCH; PUBLIC HEALTH SERVICE; RISK ASSESSMENT;

CANADA; HUMAN EXPERIMENTATION; HUMANS; MENTAL COMPETENCY; STATE GOVERNMENT; THIRD-PARTY CONSENT;

EID: 29344464314     PISSN: 07149808     EISSN: None     Source Type: Journal    
DOI: 10.1353/cja.2005.0074     Document Type: Article

References (44)

1. Alzheimer's Association. (1997). Ethical issues in dementia research: Position of the Alzheimer's Association. Chicago: Author.
2. American Geriatrics Society Ethics Committee. (1998). Informed consent for research on human subjects with dementia. Journal of the American Geriatrics Society, 46, 1308-1310.
3. American Psychiatric Association, Council on Psychiatry and Law. (1998). Guidelines for assessing the decision-making capacities of potential research subjects with cognitive impairment. American Journal of Psychiatry, 11, 1649-1650.
4. Bravo, G., Dubois, M.F., & Pâquet, M. (2003). Advance directives for health care and research: Prevalence and correlates. Alzheimer Disease and Associated Disorders, 17, 215-222.
5. Brodaty, H., Dresser, R., Eisner, M., Erkunjuntti, T., Gauthier, S., Graham, N., Jonker, C., Sachs, G., & Whitehouse, P. (1999). Consensus statement: Alzheimer's disease international and international working group for harmonization of dementia drug guidelines for research involving human subjects with dementia. Alzheimer Disease and Associated Disorders, 13, 71-79.
6. Burns, A., Rossor, M., Hecker, J., Gauthier, S., Petit, H., Möller, H.J., Rogers, S.L., Friedhoof, L.T., & the Donepezil Study Group. (1999). The effects of donepezil in Alzheimer's disease: Results from a multinational trial. Dementia and Geriatric Cognitive Disorders, 10, 237-244.
7. Canadian Study of Health and Aging Working Group. (1994). The Canadian Study of Health and Aging: Study methods and prevalence of dementia. Canadian Medical Association Journal, 150, 899-913.
8. Clark, D.C. (2001). Variability among institutional review boards and the value of local research context. Critical Care Medicine, 29, 444-445.
9. Council for International Organizations of Medical Sciences. (1993). International ethical guidelines for biomedical research involving human subjects. Geneva: Author.
10. Council of Europe. (1997, April). Convention for the protection of human rights and dignity of the human being with regard to the application of biology and medicine. Convention on human rights and biomedicine. Oviedo.
11. Etchells, E., Sharpe, G., Walsh, P., Williams, J.R., & Singer, P.A. (1996). Bioethics for clinicians: 1. Consent. Canadian Medical Association Journal, 155, 177-180.
12. Feinberg, L.F., & Whitlatch, C.J. (2001). Are persons with cognitive impairment able to state consistent choices? Gerontologist, 41, 374-382.
13. Feldman, H., Gauthier, S., Hecker, J., Vellas, B., Subbiah, P., Whalen, E., & the Donepezil MSAD Study Investigators Group. (2001). A 24-week, randomized, double-blind study of donepezil in moderate to severe Alzheimer's disease. Neurology, 57, 613-620.
14. Feldman, H., Gauthier, S., Hecker, J., Vellas, B., Emir, B., Mastey, V., Subbiah, P., & the Donepezil MSAD Study Investigators Group. (2003). Efficacy of donepezil on maintenance of activities of daily living in patients with moderate to severe Alzheimer's disease and the effect on caregiver burden. Journal of the American Geriatrics Society, 51, 737-744.
15. Fisk, J.D., Sadovnick, A.D., Cohen, C.A., Gauthier, S., Dossetor, J., Eberhart, A., & LeDuc, L. (1998). Ethical guidelines of the Alzheimer Society of Canada. Canadian Journal of Neurological Sciences, 25, 242-248.
16. Gauthier, S., Bouchard, R., Lamontagne, A., Bailey, P., Bergman, H., Ratner, J., Tesfaye, Y., Saint-Martin, M., Bacher, Y., & Carrier, L. (1990). Tetrahydroaminoacridine-lecithin combination treatment in patients with intermediate-stage Alzheimer's disease. New England Journal of Medicine, 322, 1272-1276.
17. Glass, K.C., & Lemmens, T. (2002). Research involving humans. In J. Downie, T. Caulfield & C. Flood (Eds.), Canadian Health Law and Policy (2nd ed., pp. 459-500). Toronto: Butterworths.
18. Graham, J.E., Rockwood, K., Beattie, B.L., Eastwood, R., Gauthier, S., Tuokko, H., & McDowell, I. (1997). Prevalence and severity of cognitive impairment with and without dementia in an elderly population. Lancet, 349, 1793-1796.
19. Health Canada. (2002). Canada's Aging Population. Ottawa: Division of Aging and Seniors
20. Kapp, M.B. (1999). Ethical issues in legal care. In T.F. Johnson (Ed.), Handbook on ethical issues in aging (pp. 261-270). Westport: Greenwoods.
21. Kapp, M.B. (2002). Issues in conducting research with and about older persons: Vol. 8. Ethics, law, and aging review. New York: Springer.
22. Keyserlingk, E.W., Glass, K., Kogan, S., & Gauthier, S. (1995). Proposed guidelines for the participation of persons with dementia as research subjects. Perspectives in Biology and Medicine, 38, 319-361.
23. Kim, S., Caine, E., Currier, G., Leibovici, A., & Ryan, J.M. (2001). Assessing the competence of persons with Alzheimer's disease in providing informed consent for participation in research. American Journal of Psychiatry, 158, 712-717.
24. Lazar, N.M., Greiner, G.G., Robertson, G., & Singer, P.A. (1996). Bioethics for clinicians: 5. Substitute decision-making. Canadian Medical Association Journal, 155, 1435-1437.
25. Marshall, D.T. (2000). The law of human experimentation. Toronto: Butterworths.
26. Medical Research Council of Canada. (1987). Guidelines for research involving human subjects. Ottawa: Ministry of Supply and Services Canada.
27. Medical Research Council of Canada, Natural Sciences and Engineering Research Council of Canada, & Social Sciences and Humanities Research Council of Canada. (1998) [with 2000, 2002 updates]. Tri-Council policy statement: Ethical conduct for research involving humans. Ottawa: Public Works and Government Services Canada.
28. Menikoff, J.A., Sachs, G.A., & Siegler, M. (1992). Beyond advance directives: Health care surrogate laws. New England Journal of Medicine, 327, 1165-1169.
29. Miller, T.A., Coleman, C.H., & Cugliari, A.M. (1997). Treatment decisions for patients without surrogates: Rethinking policies for a vulnerable population. Journal of the American Geriatrics Society, 45, 369-374.
30. Mohr, E., Feldman, H., & Gauthier, S. (1995). Canadian guidelines for the development of antidementia therapies: A conceptual summary. Canadian Journal of Neurological Sciences, 22, 62-71.
31. National Commission for the Protection of Human Subjects of Biomedical and Behavioral Research. (1979). The Belmont Report: Ethical principles and guidelines for the protection of human subjects of research. Washington, DC: US Government Printing Office.
32. National Council on Ethics in Human Research. (1996). Facilitating ethical research: Promoting informed consent. Discussion document. Ottawa.
33. Oldham, J.M., Haimowitz, S., & Delano, S.J. (1999). Protection of persons with mental disorders from research risk: A response to the report of the National Bioethics Advisory Commission. Archives of General Psychiatry, 56, 688-693.
34. Post, S.G., & Whitehouse, P.J. (1998). Emerging antidementia drugs: A preliminary ethical view. Journal of the American Geriatrics Society, 46, 784-787.
35. Rabins, P.V. (1998). Issues raised by research using persons suffering from dementia who have impaired decisional capacity. Journal of Health Care Law & Policy, 1, 22-35.
36. Rockwood, K., Beattie, B.L., Eastwood, M.R., Feldman, H., Mohr, E., Pryse-Phillips, W., & Gauthier, S. (1997). A randomized, controlled trial of linopirdine in the treatment of Alzheimer's disease. Canadian Journal of Neurological Sciences, 24, 140-145.
37. Rockwood, K., Macknight, C., Wentzel, C., Black, S., Bouchard, R., Gauthier, S., Feldman, H., Hogan, D., Kertesz, A., & Montgomery, P. for the CIVIC Investigators. (2000). The diagnosis of "mixed" dementia in the consortium for the investigation of vascular impairment of cognition (CIVIC). Annals New York Academy of Sciences, 903, 522-528.
38. Sachs, G.A., & Cassel, C.K. (1990). Biomedical research involving older human subjects. Law, Medicine & Health Care, 18, 234-243.
39. Silverman, H., Hull, S.C., & Sugarman, J. (2001). Variability among institutional review boards' decisions within the context of a multicenter trial. Critical Care Medicine, 29, 235-241.
40. U.S. Code of Federal Regulations. Title 45CFR46. Department of Health and Human Services, Washington, DC. Revised June 18, 1991.
41. Weijer, C. (2000). The ethical analysis of risk. Journal of Law, Medicine and Ethics, 28, 344-361.
42. Wendler, D., Martinez, R., Fairclough, D., Sunderland, T., & Ezekiel, E. (2002). Views of potential subjects toward proposed regulations for clinical research with adults unable to consent. American Journal of Psychiatry, 159, 585-591.
43. Woodward, B. (1999). Challenges to human subject protections in US medical research. Journal of the American Medical Association, 282, 1947-1952.
44. World Medical Association Declaration of Helsinki. Ethical principles for medical research involving human subjects. Adopted in Helsinki, Finland (June 1964), and amended in Tokyo, Japan (October 1975), Venice, Italy (October 1983), Hong Kong (September 1989), Somerset West, Republic of South Africa (October 1996), and Edinburgh, Scotland (October 2000).